Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Caring for Children With Medical Complexity With the Emergency Information Form.

Larson IA, Colvin JD, Hoffman A, Colliton WS, Shaw RJ.

Pediatr Emerg Care. 2020 Jan;36(1):57-61. doi: 10.1097/PEC.0000000000002021.

PMID:
31895202
2.

Pacifier Use and Breastfeeding: A Qualitative Study of Postpartum Mothers.

Rocha CR, Verga KE, Sipsma HL, Larson IA, Phillipi CA, Kair LR.

Breastfeed Med. 2020 Jan;15(1):24-28. doi: 10.1089/bfm.2019.0174. Epub 2019 Dec 20.

PMID:
31859530
3.

Exposure to Hospital Breastfeeding Support by Maternal Race and Ethnicity: A Pilot Study.

Sipsma HL, Rabinowitz MR, Young D, Phillipi C, Larson IA, Kair LR.

J Midwifery Womens Health. 2019 Nov;64(6):743-748. doi: 10.1111/jmwh.13048. Epub 2019 Oct 18.

PMID:
31625682
4.

Qualitative evaluation of how a virtual dementia experience impacts medical and pharmacy students' self-reported knowledge and attitudes towards people with dementia.

Gilmartin-Thomas JF, McNeil J, Powell A, Malone DT, Larson IC, O'Reilly CL, Kirkpatrick CM, Kipen E, Petrovich T, Ryan-Atwood TE, Bell JS.

Dementia (London). 2020 Feb;19(2):205-220. doi: 10.1177/1471301218770270. Epub 2018 Apr 16. No abstract available.

PMID:
29661097
5.

Primary Care Preparation for Children with Medical Complexity for Emergency Encounters in the Community.

Hoffman A, Larson IA.

Pediatr Ann. 2018 Mar 1;47(3):e102-e105. doi: 10.3928/19382359-20180221-02. Review.

PMID:
29538782
6.

Impact of a Virtual Dementia Experience on Medical and Pharmacy Students' Knowledge and Attitudes Toward People with Dementia: A Controlled Study.

Gilmartin-Thomas JF, McNeil J, Powell A, Malone DT, Wolfe R, Larson IC, O'Reilly CL, Kirkpatrick CM, Kipen E, Petrovich T, Bell JS.

J Alzheimers Dis. 2018;62(2):867-876. doi: 10.3233/JAD-170982.

PMID:
29480198
7.

Human Donor Milk or Formula: A Qualitative Study of Maternal Perspectives on Supplementation.

Rabinowitz MR, Kair LR, Sipsma HL, Phillipi CA, Larson IA.

Breastfeed Med. 2018 Apr;13(3):195-203. doi: 10.1089/bfm.2017.0114. Epub 2018 Feb 13.

PMID:
29437491
8.

Student Engagement with a Flipped Classroom Teaching Design Affects Pharmacology Examination Performance in a Manner Dependent on Question Type.

White PJ, Naidu S, Yuriev E, Short JL, McLaughlin JE, Larson IC.

Am J Pharm Educ. 2017 Nov;81(9):5931. doi: 10.5688/ajpe5931.

9.

Strategies to analyse data obtained from liquid intrusion experiments of loose porous materials.

Tan G, Mortona DAV, Larson I.

J Pharm Biomed Anal. 2017 Oct 25;145:711-717. doi: 10.1016/j.jpba.2017.08.004. Epub 2017 Aug 5.

PMID:
28806567
10.

The short-term and long-term effects of bariatric/metabolic surgery on subcutaneous adipose tissue inflammation in humans.

Hagman DK, Larson I, Kuzma JN, Cromer G, Makar K, Rubinow KB, Foster-Schubert KE, van Yserloo B, Billing PS, Landerholm RW, Crouthamel M, Flum DR, Cummings DE, Kratz M.

Metabolism. 2017 May;70:12-22. doi: 10.1016/j.metabol.2017.01.030. Epub 2017 Feb 2.

11.

Maximizing Health Outcomes in a Medical Home for Children with Medical Complexity: The Beacon Program.

Larson IA, Hoffman A, Artman M.

J Pediatr. 2017 Apr;183:4-5. doi: 10.1016/j.jpeds.2017.01.024. Epub 2017 Jan 25. No abstract available.

PMID:
28131491
12.

Developing a Framework for Objective Structured Clinical Examinations Using the Nominal Group Technique.

Hussainy SY, Crum MF, White PJ, Larson I, Malone DT, Manallack DT, Nicolazzo JA, McDowell J, Lim AS, Kirkpatrick CM.

Am J Pharm Educ. 2016 Nov 25;80(9):158. doi: 10.5688/ajpe809158.

13.

Enabling Noninvasive Systemic Delivery of the Kv1.3-Blocking Peptide HsTX1[R14A] via the Buccal Mucosa.

Jin L, Boyd BJ, Larson IC, Pennington MW, Norton RS, Nicolazzo JA.

J Pharm Sci. 2016 Jul;105(7):2173-9. doi: 10.1016/j.xphs.2016.05.008. Epub 2016 Jun 13.

PMID:
27312508
14.

Applying surface energy derived cohesive-adhesive balance model in predicting the mixing, flow and compaction behaviour of interactive mixtures.

Mangal S, Meiser F, Tan G, Gengenbach T, Morton DA, Larson I.

Eur J Pharm Biopharm. 2016 Jul;104:110-6. doi: 10.1016/j.ejpb.2016.04.021. Epub 2016 Apr 29.

PMID:
27132984
15.

Effect of the deformability of guest particles on the tensile strength of tablets from interactive mixtures.

Mangal S, Lakio S, Gengenbach T, Larson I, Morton DA.

Int J Pharm. 2016 Dec 5;514(2):341-352. doi: 10.1016/j.ijpharm.2016.03.038. Epub 2016 Mar 24.

PMID:
27032565
16.

Relationship between the cohesion of guest particles on the flow behaviour of interactive mixtures.

Mangal S, Gengenbach T, Millington-Smith D, Armstrong B, Morton DA, Larson I.

Eur J Pharm Biopharm. 2016 May;102:168-77. doi: 10.1016/j.ejpb.2016.03.012. Epub 2016 Mar 10.

PMID:
26972416
17.

Investigation of the Changes in Aerosolization Behavior Between the Jet-Milled and Spray-Dried Colistin Powders Through Surface Energy Characterization.

Jong T, Li J, Morton DA, Zhou QT, Larson I.

J Pharm Sci. 2016 Mar;105(3):1156-63. doi: 10.1016/S0022-3549(15)00189-6. Epub 2016 Jan 30.

18.

Pulmonary Delivery of the Kv1.3-Blocking Peptide HsTX1[R14A] for the Treatment of Autoimmune Diseases.

Jin L, Zhou QT, Chan HK, Larson IC, Pennington MW, Morales RAV, Boyd BJ, Norton RS, Nicolazzo JA.

J Pharm Sci. 2016 Feb;105(2):650-656. doi: 10.1016/j.xphs.2015.10.025. Epub 2016 Jan 12.

PMID:
26869426
19.

A Quality Improvement Collaborative to Improve Pediatric Primary Care Genetic Services.

Rinke ML, Driscoll A, Mikat-Stevens N, Healy J, Colantuoni E, Elias AF, Pletcher BA, Gubernick RS, Larson I, Chung WK, Tarini BA.

Pediatrics. 2016 Feb;137(2):e20143874. doi: 10.1542/peds.2014-3874. Epub 2016 Jan 28.

20.

Particle Engineering of Excipients for Direct Compression: Understanding the Role of Material Properties.

Mangal S, Meiser F, Morton D, Larson I.

Curr Pharm Des. 2015;21(40):5877-89. Review.

PMID:
26446468
21.

On the Methods to Measure Powder Flow.

Tan G, Morton DA, Larson I.

Curr Pharm Des. 2015;21(40):5751-65. Review.

PMID:
26446467
22.

What is the role of clinical genetics in the patient-centered medical home?: A commentary from the Medical Home Workgroup of the Heartland Regional Genetics and Newborn Screening Collaborative.

Schaefer GB, Larson IA, Bolick J, Williamson-Dean L.

Genet Med. 2016 May;18(5):440-2. doi: 10.1038/gim.2015.113. Epub 2015 Aug 20. No abstract available.

PMID:
26291599
23.

Relationship between surface concentration of L-leucine and bulk powder properties in spray dried formulations.

Mangal S, Meiser F, Tan G, Gengenbach T, Denman J, Rowles MR, Larson I, Morton DA.

Eur J Pharm Biopharm. 2015 Aug;94:160-9. doi: 10.1016/j.ejpb.2015.04.035. Epub 2015 May 22.

PMID:
26007290
24.

The role of physico-chemical and bulk characteristics of co-spray dried L-leucine and polyvinylpyrrolidone on glidant and binder properties in interactive mixtures.

Mangal S, Meiser F, Lakio S, Morton D, Larson I.

Int J Pharm. 2015 Feb 20;479(2):338-48. doi: 10.1016/j.ijpharm.2015.01.001. Epub 2015 Jan 5.

PMID:
25572691
25.

Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders.

Soden SE, Saunders CJ, Willig LK, Farrow EG, Smith LD, Petrikin JE, LePichon JB, Miller NA, Thiffault I, Dinwiddie DL, Twist G, Noll A, Heese BA, Zellmer L, Atherton AM, Abdelmoity AT, Safina N, Nyp SS, Zuccarelli B, Larson IA, Modrcin A, Herd S, Creed M, Ye Z, Yuan X, Brodsky RA, Kingsmore SF.

Sci Transl Med. 2014 Dec 3;6(265):265ra168. doi: 10.1126/scitranslmed.3010076.

26.

Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages.

Kratz M, Coats BR, Hisert KB, Hagman D, Mutskov V, Peris E, Schoenfelt KQ, Kuzma JN, Larson I, Billing PS, Landerholm RW, Crouthamel M, Gozal D, Hwang S, Singh PK, Becker L.

Cell Metab. 2014 Oct 7;20(4):614-25. doi: 10.1016/j.cmet.2014.08.010. Epub 2014 Sep 18.

27.

Primary-care providers' perceived barriers to integration of genetics services: a systematic review of the literature.

Mikat-Stevens NA, Larson IA, Tarini BA.

Genet Med. 2015 Mar;17(3):169-76. doi: 10.1038/gim.2014.101. Epub 2014 Sep 11. Review.

PMID:
25210938
28.

An insight into powder entrainment and drug delivery mechanisms from a modified Rotahaler®.

Sim S, Margo K, Parks J, Howell R, Hebbink GA, Orlando L, Larson I, Leslie P, Ho L, Morton DA.

Int J Pharm. 2014 Dec 30;477(1-2):351-60. doi: 10.1016/j.ijpharm.2014.08.038. Epub 2014 Sep 6.

PMID:
25196720
29.

Macrophage metalloelastase (MMP12) regulates adipose tissue expansion, insulin sensitivity, and expression of inducible nitric oxide synthase.

Lee JT, Pamir N, Liu NC, Kirk EA, Averill MM, Becker L, Larson I, Hagman DK, Foster-Schubert KE, van Yserloo B, Bornfeldt KE, LeBoeuf RC, Kratz M, Heinecke JW.

Endocrinology. 2014 Sep;155(9):3409-20. doi: 10.1210/en.2014-1037. Epub 2014 Jun 10.

30.

Effect of surface coating with magnesium stearate via mechanical dry powder coating approach on the aerosol performance of micronized drug powders from dry powder inhalers.

Zhou QT, Qu L, Gengenbach T, Larson I, Stewart PJ, Morton DA.

AAPS PharmSciTech. 2013 Mar;14(1):38-44. doi: 10.1208/s12249-012-9895-z. Epub 2012 Nov 30.

31.

Characterizing and quantifying leukocyte populations in human adipose tissue: impact of enzymatic tissue processing.

Hagman DK, Kuzma JN, Larson I, Foster-Schubert KE, Kuan LY, Cignarella A, Geamanu E, Makar KW, Gottlieb JR, Kratz M.

J Immunol Methods. 2012 Dec 14;386(1-2):50-9. doi: 10.1016/j.jim.2012.08.018. Epub 2012 Sep 10.

32.

Understanding the interfacial properties of nanostructured liquid crystalline materials for surface-specific delivery applications.

Dong YD, Larson I, Barnes TJ, Prestidge CA, Allen S, Chen X, Roberts CJ, Boyd BJ.

Langmuir. 2012 Sep 18;28(37):13485-95. doi: 10.1021/la302435g. Epub 2012 Aug 31.

PMID:
22889049
33.

Powder strength distributions for understanding de-agglomeration of lactose powders.

Das SC, Behara SR, Bulitta JB, Morton DA, Larson I, Stewart PJ.

Pharm Res. 2012 Oct;29(10):2926-35. doi: 10.1007/s11095-012-0799-0. Epub 2012 Jun 14.

PMID:
22695732
34.

Insight into pressure drop dependent efficiencies of dry powder inhalers.

Behara SR, Larson I, Kippax P, Stewart P, Morton DA.

Eur J Pharm Sci. 2012 Jun 14;46(3):142-8.

PMID:
22586728
35.

Cell surface hydrophobicity of colistin-susceptible vs resistant Acinetobacter baumannii determined by contact angles: methodological considerations and implications.

Soon RL, Li J, Boyce JD, Harper M, Adler B, Larson I, Nation RL.

J Appl Microbiol. 2012 Oct;113(4):940-51. doi: 10.1111/j.1365-2672.2012.05337.x.

36.

The kinetics of cohesive powder de-agglomeration from three inhaler devices.

Behara SR, Larson I, Kippax P, Morton DA, Stewart P.

Int J Pharm. 2011 Dec 12;421(1):72-81. doi: 10.1016/j.ijpharm.2011.09.024. Epub 2011 Sep 21.

PMID:
21963469
37.

Effect of colistin exposure and growth phase on the surface properties of live Acinetobacter baumannii cells examined by atomic force microscopy.

Soon RL, Nation RL, Harper M, Adler B, Boyce JD, Tan CH, Li J, Larson I.

Int J Antimicrob Agents. 2011 Dec;38(6):493-501. doi: 10.1016/j.ijantimicag.2011.07.014. Epub 2011 Sep 16.

38.

Chitosan nanoparticles enhance the plasma exposure of (-)-epigallocatechin gallate in mice through an enhancement in intestinal stability.

Dube A, Nicolazzo JA, Larson I.

Eur J Pharm Sci. 2011 Oct 9;44(3):422-6. doi: 10.1016/j.ejps.2011.09.004. Epub 2011 Sep 8.

PMID:
21925598
39.

Assessment of plasma concentrations of (-)-epigallocatechin gallate in mice following administration of a dose reflecting consumption of a standard green tea beverage.

Dube A, Nicolazzo JA, Larson I.

Food Chem. 2011 Sep 1;128(1):7-13. doi: 10.1016/j.foodchem.2011.02.038. Epub 2011 Mar 21.

PMID:
25214322
40.

Use of surface energy distributions by inverse gas chromatography to understand mechanofusion processing and functionality of lactose coated with magnesium stearate.

Das SC, Zhou Q, Morton DA, Larson I, Stewart PJ.

Eur J Pharm Sci. 2011 Jul 17;43(4):325-33. doi: 10.1016/j.ejps.2011.05.012. Epub 2011 May 20.

PMID:
21621612
41.

Investigation of the extent of surface coating via mechanofusion with varying additive levels and the influences on bulk powder flow properties.

Zhou QT, Qu L, Gengenbach T, Denman JA, Larson I, Stewart PJ, Morton DA.

Int J Pharm. 2011 Jul 15;413(1-2):36-43. doi: 10.1016/j.ijpharm.2011.04.014. Epub 2011 Apr 16.

PMID:
21527321
42.

Adsorption of nonlamellar nanostructured liquid-crystalline particles to biorelevant surfaces for improved delivery of bioactive compounds.

Dong YD, Larson I, Barnes TJ, Prestidge CA, Boyd BJ.

ACS Appl Mater Interfaces. 2011 May;3(5):1771-80. doi: 10.1021/am2003069. Epub 2011 May 9.

PMID:
21506614
43.

Characterization of the surface properties of a model pharmaceutical fine powder modified with a pharmaceutical lubricant to improve flow via a mechanical dry coating approach.

Zhou QT, Denman JA, Gengenbach T, Das S, Qu L, Zhang H, Larson I, Stewart PJ, Morton DAV.

J Pharm Sci. 2011 Aug;100(8):3421-3430. doi: 10.1002/jps.22547. Epub 2011 Mar 31.

PMID:
21455980
44.

Determination of the polar and total surface energy distributions of particulates by inverse gas chromatography.

Das SC, Larson I, Morton DA, Stewart PJ.

Langmuir. 2011 Jan 18;27(2):521-3. doi: 10.1021/la104135z. Epub 2010 Dec 21.

PMID:
21174410
45.

Structural influence of cohesive mixtures of salbutamol sulphate and lactose on aerosolisation and de-agglomeration behaviour under dynamic conditions.

Behara SR, Kippax P, McIntosh MP, Morton DA, Larson I, Stewart P.

Eur J Pharm Sci. 2011 Feb 14;42(3):210-9. doi: 10.1016/j.ejps.2010.11.008. Epub 2010 Nov 26.

PMID:
21112390
46.

Different surface charge of colistin-susceptible and -resistant Acinetobacter baumannii cells measured with zeta potential as a function of growth phase and colistin treatment.

Soon RL, Nation RL, Cockram S, Moffatt JH, Harper M, Adler B, Boyce JD, Larson I, Li J.

J Antimicrob Chemother. 2011 Jan;66(1):126-33. doi: 10.1093/jac/dkq422. Epub 2010 Nov 16.

47.

Design, synthesis, and evaluation of a new fluorescent probe for measuring polymyxin-lipopolysaccharide binding interactions.

Soon RL, Velkov T, Chiu F, Thompson PE, Kancharla R, Roberts K, Larson I, Nation RL, Li J.

Anal Biochem. 2011 Feb 15;409(2):273-83. doi: 10.1016/j.ab.2010.10.033. Epub 2010 Nov 2.

48.

Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water-soluble drugs II. In-vivo evaluation.

Nguyen TH, Hanley T, Porter CJ, Larson I, Boyd BJ.

J Pharm Pharmacol. 2010 Jul;62(7):856-65. doi: 10.1211/jpp.62.06.0006.

PMID:
20636873
49.
50.

Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (-)-epigallocatechin gallate.

Dube A, Nicolazzo JA, Larson I.

Eur J Pharm Sci. 2010 Oct 9;41(2):219-25. doi: 10.1016/j.ejps.2010.06.010. Epub 2010 Jun 19.

PMID:
20600878

Supplemental Content

Loading ...
Support Center